Literature DB >> 9553099

Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.

Z Chen1, X Zhang, N C Gonnella, T C Pellas, W C Boyar, F Ni.   

Abstract

The functions of the C5a anaphylatoxin are expressed through its interaction with a cell-surface receptor with seven transmembrane helices. The interaction of C5a with the receptor has been explained by a two-site model whereby recognition and effector sites on C5a bind, respectively, to recognition and effector domains on the receptor, leading to receptor activation (Chenoweth, D. E., and Hugli, T. E. (1980) Mol. Immunol. 17, 151-161. In addition, the extracellular N-terminal region of the C5a receptor has been implicated as the recognition domain for C5a, responsible for approximately 50% of the binding energy of the C5a-receptor complex (Mery, L., and Boulay, F. (1994) J. Biol. Chem. 269, 3457-3463; DeMartino, J. A., Van Riper, G., Siciliano, S. J., Molineaux, C. J., Konteatis, Z. D., Rosen, H., and Springer, M. S. (1994) J. Biol. Chem. 269, 14446-14450). In this work, the interactions of C5a with the N-terminal domain of the C5a receptor were examined by use of recombinant human C5a molecules and peptide fragments M1NSFN5YTTPD10YGHYD15DKDTL20DLNTP25VDKTS30NTLR(hC5aRF-1-34), acetyl-HYD15DKDTL20DLNTP25VDKTS30NTLR (hC5aRF-13-34), and acetyl-TL20DLNTP25VDKTS30N-amide (hC5aRF-19-31) derived from human C5a receptor. Binding induced resonance perturbations in the NMR spectra of the receptor fragments and the C5a molecules indicated that the isolated Nterminal domain or residues 1-34 of the C5a receptor retain specific binding to C5a and to a C5a analog devoid of the agonistic C-terminal tail in the intact C5a. Residues of C5a perturbed by the binding of the receptor peptides are localized within the helical core of the C5a structure, in agreement with the results from functional studies employing mutated C5a and intact receptor molecules. All three receptor peptides, hC5aRF-1-34, hC5aRF-13-34, and hC5aRF-19-31, responded to the binding of C5a through the 21-30 region containing either hydrophobic, polar, or positively charged residues such as Thr24, Pro25, Val26, Lys28, Thr29, and Ser30. The 21-30 segment of all three receptor fragments was found to have a partially folded conformation in solution, independent of residues 1-18. These results indicate that a short peptide sequence, or residues 21-30, of the C5a receptor N terminus may constitute the binding domain for the recognition site on C5a.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9553099     DOI: 10.1074/jbc.273.17.10411

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Aptamers that bind to the human complement component receptor hC5aR1 interfere with hC5aR1 interaction to its hC5a ligand.

Authors:  Penmetcha K R Kumar
Journal:  Mol Biol Rep       Date:  2018-07-06       Impact factor: 2.316

2.  The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.

Authors:  Anne-Marie Scola; Adrian Higginbottom; Lynda J Partridge; Robert C Reid; Trent Woodruff; Stephen M Taylor; David P Fairlie; Peter N Monk
Journal:  J Biol Chem       Date:  2006-12-11       Impact factor: 5.157

Review 3.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Structure of the tyrosine-sulfated C5a receptor N terminus in complex with chemotaxis inhibitory protein of Staphylococcus aureus.

Authors:  Johannes H Ippel; Carla J C de Haas; Anton Bunschoten; Jos A G van Strijp; John A W Kruijtzer; Rob M J Liskamp; Johan Kemmink
Journal:  J Biol Chem       Date:  2009-02-27       Impact factor: 5.157

Review 5.  Function, structure and therapeutic potential of complement C5a receptors.

Authors:  P N Monk; A-M Scola; P Madala; D P Fairlie
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

6.  A peptide mimic of the chemotaxis inhibitory protein of Staphylococcus aureus: towards the development of novel anti-inflammatory compounds.

Authors:  Anton Bunschoten; Johannes H Ippel; John A W Kruijtzer; Louris Feitsma; Carla J C de Haas; Rob M J Liskamp; Johan Kemmink
Journal:  Amino Acids       Date:  2010-08-04       Impact factor: 3.520

7.  Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response.

Authors:  Andrew J Wright; Adrian Higginbottom; Didier Philippe; Abhishek Upadhyay; Stefan Bagby; Robert C Read; Peter N Monk; Lynda J Partridge
Journal:  Mol Immunol       Date:  2007-01-26       Impact factor: 4.407

8.  Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor.

Authors:  M Farzan; C E Schnitzler; N Vasilieva; D Leung; J Kuhn; C Gerard; N P Gerard; H Choe
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

9.  Structural and functional characterization of human and murine C5a anaphylatoxins.

Authors:  Janus Asbjørn Schatz-Jakobsen; Laure Yatime; Casper Larsen; Steen Vang Petersen; Andreas Klos; Gregers Rom Andersen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-05-30

10.  Label-Free Quantitative Proteomic Analysis of Differentially Expressed Membrane Proteins of Pulmonary Alveolar Macrophages Infected with Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus and Its Attenuated Strain.

Authors:  Zehui Qu; Fei Gao; Liwei Li; Yujiao Zhang; Yifeng Jiang; Lingxue Yu; Yanjun Zhou; Hao Zheng; Wu Tong; Guoxin Li; Guangzhi Tong
Journal:  Proteomics       Date:  2017-11-24       Impact factor: 3.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.